With key tax credit under microscope, biotech firms say it should stay, be improved

But not everyone is happy with the SR&ED program. Critics say it’s ineffective and complicated.

Paul Lem, CEO and founder of the Ottawa-based biotechnology company Spartan Bioscience, has gotten back millions of dollars from the SR&ED tax-credit program over the years. The Hill Times photograph by Sam Garcia

PUBLISHED :Wednesday, Sept. 20, 2017 12:00 AM

If you are already a subscriber

Subscribe to The Hill Times

Subscribe to the digital and/or print editions and get instant access to The Hill Times online.

Quick Purchase

Purchase Story Issue in electronic format (PDF) for $5.00.